ENTO
Entero Therapeutics
ENTO
ENTO
10 hedge funds and large institutions have $47.6K invested in Entero Therapeutics in 2025 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
10
Holders Change
+2
Holders Change %
+25%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
TSS
1
Two Sigma Securities
New York
|
$6.31K |
2 |
2
Jane Street
New York
|
$5.09K |
3 |
3
Renaissance Technologies
New York
|
$5K |
4 |
4
Citadel Advisors
Miami,
Florida
|
$4.97K |
5 |
5
Bank of America
Charlotte,
North Carolina
|
$17 |
Top Sellers
1 |
1
UBS Group
Zurich,
Switzerland
|
$8.22K |
2 |
HF
2
HRT Financial
New York
|
$0 |
3 |
JC
3
JB Capital
Wethersfield,
Connecticut
|
$0 |
4 |
TRCT
4
Tower Research Capital (TRC)
New York
|
$2.03K |